Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  GlaxoSmithKline plc    GS7   GB0009252882

Delayed Quote. Delayed  - 06/28 05:08:24 pm
18.516 EUR   +0.41%
06/21 INNOVIVA : FULFIL study shows superiority of closed triple combinati..
06/20DJGlaxoSmithKline COPD Triple Combination Study Shows Improved Lung..
06/20 TOP NEWS : Glaxo Gets Positive Top-Line Results On COPD Treatment
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo GlaxoSmithKline plc
Develops, manufactures and distributes vaccines and other pharmaceutical products

GlaxoSmithKline Plc operates as a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands.

It operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare.

The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases.

The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis.

The Consumer Healthcare business markets a range of consumer health products based on scientific innovation.

The company was founded on December 6, 1999 and is headquartered in Brentford, United Kingdom.
Managers
NameAgeSinceTitle
Andrew Witty502008Chief Executive Officer & Executive Director
Philip Hampton522015Non-Executive Chairman
Simon Dingemans512011Chief Financial Officer & Executive Director
Moncef Slaoui, PhD552006Executive Director & Chairman-Global Vaccines
Roy Malcolm Anderson672007Independent Non-Executive Director
Stacey Cartwright512011Independent Non-Executive Director
Judy Carol Lewent662011Independent Non-Executive Director
Lynn Laverty Elsenhans, MBA592012Independent Non-Executive Director
Urs Rohner572015Independent Non-Executive Director
Manvinder Singh Banga612015Senior Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 5,363,351,178 4,831,692,170 90.1% 491,515,950 9.2% 90.1%
Shareholders
NameEquities%
BlackRock Investment Management (UK) Ltd. 199,772,316 4.10%
Legal & General Investment Management Ltd. 149,809,659 3.08%
The Vanguard Group, Inc. 116,481,945 2.39%
Capital Research & Management Co. (Global Investors) 102,630,000 2.11%
Norges Bank Investment Management 91,688,000 1.88%
State Street Global Advisors Ltd. 61,993,952 1.27%
Aberdeen Asset Investments Ltd. 60,202,814 1.24%
Threadneedle Asset Management Ltd. 60,083,403 1.23%
GlaxoSmithKline Employee Trust 52,734,605 1.08%
Woodford Investment Management LLP 52,415,660 1.08%
Holdings
NameEquities%Valuation
Aspen Pharmacare Holdings Limited (APNJ) 28,234,3796.19%578,043,571 USD
Innoviva Inc (THRX) 32,005,26028.3%361,019,333 USD
Theravance Biopharma Inc (TBPH) 9,644,80720.3%221,830,561 USD
GlaxoSmithKline S.A.E. 76,161,37891.2%79,935,936 USD
Dong-A Socio Holdings Co Ltd (000640) 409,6938.46%66,001,895 USD
GlaxoSmithKline Consumer Nigeria PLC (GLAXOSM) 555,081,92646.4%58,561,143 USD
Oncomed Pharmaceuticals Inc (OMED) 2,607,5468.61%38,617,756 USD
Allergy Therapeutics plc (AGY) 10,118,0001.72%3,644,908 USD
NeuroSearch A/S (NEUR) 1,950,5007.94%805,693 USD
Response Genetics, Inc. (RGDXQ) 5,000,00012.9%15,000 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
ROCHE HOLDING LTD..
PFIZER INC.
NOVARTIS AG
MERCK & CO., INC.
BRISTOL-MYERS SQU..
NOVO NORDISK A/S
SANOFI
GLAXOSMITHKLINE P..
ALLERGAN PLC
ELI LILLY AND CO
BAYER AG
ASTRAZENECA PLC
ABBOTT LABORATORI..
SHIRE PLC
TEVA PHARMACEUTIC..
-
ASTELLAS PHARMA I..
TAKEDA PHARMACEUT..
MYLAN NV
CHUGAI PHARMACEUT..
Sector Pharmaceuticals
GlaxoSmithKline plc : Connections
European Federation of Pharmaceutical Industries & Assns
Mauser Group NV
The Council for Industry & Higher Education
Alfred Escher-Stiftung
The 100 Group
Business Council for Britain
National Theatre of Scotland
The Institute of International Finance, Inc.
Biotechnology Industry Organization
International Institute for Management Development
International AIDS Vaccine Initiative, Inc.
Diversey, Inc.
Longwood Fund Management LLC
United Way of Greater Philadelphia & Southern New Jersey
The Natural History Museum
Credit Suisse Americas Foundation
Institute of Medicine
Opernhaus Zürich AG
French Academy of Sciences
Economiesuisse
Imperial College London
Swiss Finance Council
Pearson Education Ltd.
Diversey Holdings, Inc.
Harvey Nichols Group Ltd.
World Presidents' Organization
Burberry Spain SA
Central Houston, Inc.
Singapore Economic Development Board
The First Tee of Greater Houston
The University of Nottingham
Credit Suisse AG
Rockefeller Family Trust, Inc.
Zurich Chamber of Commerce
American Academy of Arts & Sciences
Institute International d'Etudes Bancaires
Massachusetts Institute of Technology
Lucerne Festival
Sunoco Chemicals, Inc.
Avenir Suisse
Sunoco Partners LLC
IMD Scholarship Foundation
Pharmaceutical Research & Manufacturers of America
Swiss Bankers Association
Indian School of Business
European Financial Services Round Table
United Kingdom Department for Business, Innovation & Skills
GlaxoSmithKline, Inc.
Rice University
World Golf Foundation, Inc.
Indian Institute of Management
The Texas Medical Center
The Indus Entrepreneurs (Delhi)
United Way of Greater Houston
Clayton Dubilier & Rice LLP
Company contact information
980 Great West road
TW8 9GS Brentford, Greater London
United Kingdom

Phone : +44 (0)20 8047 5000
Fax : +44 (0)20 8047 7807
Internet : http://www.gsk.com
Markets and indexes
- London Stock Exchange, SETS
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, Stoxx Global 200, Stoxx UK 50
Stock Exchange Codes
- ISIN Code :  GB0009252882
- Bloomberg Code :  GSK:LN
- Reuters Code :  GSK.L
- Datastream Code :  GSK
© 2016 People , Fundamentals and Ownership    © 2016 Cofisem